Discover trends, market shifts, and competitive outlooks for the proteomics industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What is the Anticipated CAGR of the Proteomics Market, and What Factors Will Drive It?

The growth of the proteomics market has been swift in the past few years. The market is set to expand from a size of $34.83 billion in 2024 to a size of $39.71 billion in 2025, with a compound annual growth rate (CAGR) of 14.0%. The growth during the historic period can be traced back to an increase in governmental funding for proteomics research, technological advancements, an upsurge in healthcare spending, an expansion in the number of healthcare facilities, and economic growth in the emerging markets.

The market for proteomics is projected to experience a swift expansion in the forthcoming years. The size of the market is anticipated to surge to $66.18 billion by 2029, with a compound annual growth rate (CAGR) of 13.6%. The predicted growth in this period is due to factors like increased funding for proteomics initiatives, a growing demand for personalized medicine, escalated research and development activities, and a boost in investments in biotech firms in response to the COVID-19 pandemic. Significant tendencies during this forecast period encompass emphasis on incorporating nanotechnology for the detection of low-abundant samples, the evolution and improvement of new techniques, the introduction of new commodities, and investment in technologies such as artificial intelligence (ai) and real-time enhanced imaging.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=2828&type=smp

What are the Fundamental Drivers and Innovations Shaping the Proteomics Market?

The expansion of the proteomics market is propelled by escalating government investments in proteomics research. Government financing aids in the exploration of drugs, diagnosis, and disease management. For example, Proteomics International Laboratories Limited, a medical technology firm based in Australia specializing in proteomics, received $400,000 in funding in May 2022 to enhance its production capacity in Australia. The funding is intended to advance the production of the PromarkerD test in Australia and South-East Asia, which includes broadening Proteomics International’s ISO 13485 certification. Consequently, the proteomics market benefits significantly from increasing government funding.

How Is the Proteomics Market Segmented?

The proteomics market covered in this report is segmented –

1) By Component: Reagents, Instruments, Software

2) By Instrument: Protein Microarrays, Spectroscopy, X-ray Crystallography, Chromatography, Electrophoresis, Surface Plasmon Resonance, Protein Fractionation

3) By Type: Core Instrument Services, Proteomic Analytical Services

Subsegments:

1) By Reagents: Protein Assays, Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Electrophoresis Reagents

2) By Instruments: Mass Spectrometry, Chromatography Equipment, Electrophoresis Equipment, Microarray Instruments, X-ray Crystallography Instruments

3) By Software: Data Analysis Software, Bioinformatics Tools, Cloud-Based Platforms For Proteomics

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=2828&type=smp

Which Regions Are Driving the Next Phase of the Proteomics Market Growth?

North America was the largest region in the proteomics market in 2024. Western Europe was the second largest region in the global proteomics market share. The regions covered in the proteomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Key Trends Are Shaping the Future of the Proteomics Market?

To boost their earnings and achieve a competitive advantage over their competition, firms are introducing new products. For example, in June 2022, Bruker Corporation, a scientific instrument manufacturer based in the United States, revealed the next innovation of its pioneering 4D Multiomics timsTOF platform by launching the new timsTOF HT system. This system comes with a cutting-edge 4th-generation TIMS (trapped ion mobility separation) XR cell and a 14-bit digitizer, providing a wider dynamic range, increased peptide coverage, and enhanced quantitation precision, particularly in unbiased 4D plasma and tissue proteomics and epiproteomics.

View the full report here:

https://www.thebusinessresearchcompany.com/report/proteomics-global-market-report

How Is the Proteomics Market Defined and What Are Its Core Parameters?

Proteomics is the study of the structure and functions of proteins that are used in drug discovery, diagnosis, and treatment of diseases. Proteomics is used to evaluate the protein production rate, the involvement of proteins in metabolic pathways, and the modifications of proteins.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2828

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model